Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Rosenstock J, Wysham C, Fras JP, et al Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
Your provider will specify this
Researchers can access the Certificate of Analysis library directly through the Amino USA website, allowing independent verification before purchasing
As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, Mounjaro works by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying
Adults with type 2 diabetes have lower risks for death and major adverse cardiovascular and kidney events if they use tirzepatide compared with GLP-1 receptor agonists, according to observational data published in JAMA Network Open
Increased sexual desire was reported after 68% of Melanotan II doses versus 19% of placebo doses, demonstrating effects on both erectile function and libido
US$ 20.64
US$ 21.13
US$ 28.21
US$ 20.47
US$ 26.89
US$ 23.23
%20powder-1.png)
US$ 20.46
US$ 23.54
US$ 26.51
